Tenon Medical
TNON
21 hedge funds and large institutions have $1.82M invested in Tenon Medical in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 0 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
75% more funds holding
Funds holding: 12 → 21 (+9)
63% more capital invested
Capital invested by funds: $1.12M → $1.82M (+$703K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAMC
Spectrum Asset Management (California)
Newport Beach,
California
|
+$240K |
| 2 |
CB
Commerce Bank
Kansas City,
Missouri
|
+$138K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$45.9K |
| 4 |
State Street
Boston,
Massachusetts
|
+$40.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$45.9K |
TNON Hedge Fund Activity: Q4 2022 in Review
21 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Tenon Medical (TNON) for Q4 2022, worth a combined $1.82M — up 63% from $1.12M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TNON positions and 0 closed out — a net gain of 9 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Spectrum Asset Management (California), opening a new position worth an estimated $240K. The largest seller was Morgan Stanley, cutting an estimated $45.9K.
- 21 institutional investors held Tenon Medical (TNON) as of Q4 2022, up from 12 in Q3 2022.
- Funds reported $1.82M of Tenon Medical stock for Q4 2022, up 63% quarter-over-quarter.
- 9 funds opened new Tenon Medical positions in Q4 2022 and 0 closed out, a net change of +9 holders.
- The largest Tenon Medical buyer in Q4 2022 was Spectrum Asset Management (California), an estimated $240K added.
- The largest Tenon Medical seller in Q4 2022 was Morgan Stanley, an estimated $45.9K sold.
Based on aggregated 13F filings for Q4 2022.